Treatment
Medication clinical trials
We’re tracking 7,458 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT05297708Recruiting
Blood pressure monitoring at home, office, and with a 24-hour device
This study compares blood pressure readings taken at home, in the doctor's office, and over a full 24-hour period using a portable monitor. It may help understand the best way to track blood pressure in children and teens with slightly high blood pressure.
Cincinnati, OhioAges 6–19 - NCT05299814Recruiting
Study how parent emotion skills affect ADHD treatment
This study looks at whether helping parents manage their emotions can improve how their child with ADHD does. You may be asked to track emotions and behavior at home to better understand what supports work best.
Hershey, PennsylvaniaAges 5–12 - NCT05300464Recruiting
Test MammoWave for finding breast lesions on imaging
This study checks how well MammoWave can help detect breast lesions (areas that may be abnormal) using imaging. It may help doctors confirm findings by combining it with other scans when needed, and sometimes with biopsy results.
Genova, GenovaAges 18 years+ - NCT05302271RecruitingPhase 1
Testing gene therapy for Friedreich’s ataxia heart disease
This Phase 1 trial tests an AAV gene therapy that aims to improve heart problems caused by Friedreich’s ataxia. You may be eligible if you have genetically confirmed Friedreich’s ataxia with measurable heart weakening but still enough heart function to safely receive treatment.
New York, New YorkAges 12–50 - NCT05302999RecruitingPhase 4
Early gabapentin for recovery after spinal cord injury
This trial studies whether starting gabapentin within 5 days after a traumatic spinal cord injury is safe and helpful for early recovery. It will mainly look at feasibility—whether patients can take the medicine and whether it affects early neurologic progress.
Cleveland, OhioAges 18 years+ - NCT05304208RecruitingPhase 1
Mesothelioma trial using immune cells plus surgery
This early-phase study tests a treatment that uses a patient’s immune cells (dendritic cell therapy) combined with surgery for epithelioid mesothelioma. It aims to help the immune system better recognize and attack the cancer after chemotherapy and before/around surgery.
Rotterdam, South HollandAges 18 years+ - NCT05312892RecruitingPhase 1/Phase 2
Study for weight-related hormone signals in people with high blood pressure
This early-phase study looks at how the body’s “fight-or-flight” signals may be involved in weight gain (obesity) and high blood pressure. It may help researchers understand the biology and guide future treatments.
Nashville, TennesseeAges 18–65 - NCT05316103Recruiting
Optical biopsy of rectal scars after cancer treatment
This trial tests a targeted “optical biopsy” (using a special light-based exam to sample tissue) to better assess rectal scars after standard chemotherapy and radiation before surgery. It may help surgeons choose the most appropriate way to operate on rectal cancer.
Guangzhou, GuangdongAges 18–80 - NCT05317403RecruitingPhase 1
Venetoclax plus chemo to change cancer cell behavior
This Phase 1 trial tests whether venetoclax, combined with chemotherapy and a “cancer cell behavior” medicine strategy, can improve treatment for people with AML that has come back or not gone into remission. It’s mainly looking at safety and early signs of benefit.
Milwaukee, WisconsinAges 1–25 - NCT05319015RecruitingPhase 2
Lenvatinib plus pembrolizumab before kidney surgery for IVC tumor
This trial studies lenvatinib and pembrolizumab given before surgery to treat kidney cancer that has grown into a large vein (the IVC) near the liver or heart. The goal is to shrink or control the tumor thrombus and make treatment and surgery more effective and safer.
Dallas, TexasAges 18 years+ - NCT05322824Recruiting
Study for adults with narrowed brain or neck arteries
This study enrolls people age 40 or older who have at least 50% narrowing in one brain or neck (carotid) artery. It collects clinical information to better understand this condition and how patients are doing over time.
Hangzhou, ZhejiangAges 40 years+ - NCT05322343Recruiting
Study biobank and brain health in people age 55–80
This study collects blood samples to build a biobank and learn how brain health changes with age. Some participants may also do an MRI scan to better understand brain changes and immune response.
Bordeaux, BordeauxAges 55–80 - NCT05323201RecruitingPhase 1/Phase 2
B7H3 CAR-T therapy for advanced liver cancer
This trial tests an immune therapy made from your own blood cells (CAR-T) to treat advanced, unresectable liver cancer. It’s designed for people whose tumor has a specific marker called B7H3 and who meet blood, organ, and safety requirements.
Xuzhou, JiangsuAges 18–70 - NCT05324332Recruiting
Two scans to study prostate cancer in the same group
This trial looks at prostate cancer patients who have not started treatment yet and have two different PET/CT scans close together. It may help doctors compare how these scans show prostate cancer in the body.
Beijing, Beijing MunicipalityAges 18–90 - NCT05324748RecruitingPhase 3
Repeated nerve-block shots for chronic cluster headache
This Phase 3 trial tests whether repeated injections can reduce attacks of chronic cluster headache. It may help people who have frequent, consistent attacks and can track them closely during the study.
LeidenAges 18–70 - NCT05324488Recruiting
Graz diabetes registry for studying blood biomarkers
This study is a diabetes registry that collects health and blood information to learn what “biomarkers” (measurable signs in the body) can tell us about diabetes and related conditions. It may help researchers better understand diabetes and possibly improve future testing or care.
GrazAges 18–99 - NCT05326061Recruiting
Study for people at high risk of getting HIV
This registry study looks at people who are HIV-negative but at high risk of getting HIV, to better understand risk and care needs. If you qualify, you may be asked to share health and behavior information to help guide future prevention efforts.
ViennaAges 18–100 - NCT05326477Recruiting
Study factors that predict how well behavioral weight plans work
This study looks at which personal and health factors help or hurt how well behavioral obesity treatments work. It may help doctors better tailor weight-treatment plans for people with obesity.
Chicago, IllinoisAges 18 years+ - NCT05327517Recruiting
Surgery or chemo-radiation for cervical esophagus cancer
This study compares two ways to treat cervical esophagus squamous cell cancer: surgery alone versus chemo-radiation (chemotherapy plus radiation). It may help find the best approach to control the cancer while keeping side effects manageable.
BeijingAges 18–75 - NCT05328999Recruiting
Study links fertility, pregnancy loss, and gut microbes
This trial studies how gut bacteria (your “microbiome”) may relate to infertility, recurrent pregnancy loss, and time to pregnancy. It may help researchers understand what could be changed to improve fertility outcomes.
Graz, StyriaAges 18–50 - NCT05330923Recruiting
HIV and fatty liver check-in study with ultrasound follow-up
This study follows people with HIV who also have fatty liver disease and checks their health over time. It may help by improving monitoring and care planning, especially using ultrasound scans and regular follow-up.
Beijing, Beijing MunicipalityAges Any age - NCT05331911RecruitingPhase 4
Propofol anesthesia vs sevoflurane for liver tumor surgery
This study compares two types of general anesthesia—propofol-based total intravenous anesthesia versus sevoflurane inhaled anesthesia—during planned surgery to remove liver tumors. The goal is to see whether the anesthesia choice affects long-term outcomes after partial liver removal for hepatocellular carcinoma.
Kaohsiung CityAges 20–80 - NCT05331170RecruitingPhase 2
Re-training the nose to change how allergies behave
This Phase 2 study tests a “viral” treatment meant to reprogram the lining of your nose to reduce allergy-like immune responses. It is testing whether this approach is safe and can help people with cat allergy (with or without asthma) or compare against healthy people.
Galveston, TexasAges 18–60 - NCT05332613Recruiting
Diet and meal timing study for fatty liver
This study looks at whether changing when and how people eat can improve fatty liver disease caused by metabolic problems. It uses MRI to measure liver fat and compares outcomes while participants follow a structured eating schedule.
New York, New YorkAges 18–65
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,458 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.